首页> 外文OA文献 >Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons
【2h】

Mechanism of bis(7)-tacrine inhibition of GABA-activated current in cultured rat hippocampal neurons

机译:bis(7)-他克林抑制培养的大鼠海马神经元GABA激活电流的机制

摘要

Bis(7)-tacrine is a novel dimeric acetylcholinesterase inhibitor derived from tacrine that shows promise for the treatment of Alzheimer's disease. We have previously reported that bis(7)-tacrine inhibits GABA A receptors. In the present study we investigated the mechanism of bis(7)-tacrine inhibition of GABA A receptor function using whole-cell patch-clamp recording in cultured rat hippocampal neurons. Bis(7)-tacrine produced a gradual decline of GABA-activated current to a steady-state, but this was not an indication of use-dependence, as the gradually declining component could be eliminated by exposure to bis(7)-tacrine prior to GABA application. In addition, bis(7)-tacrine inhibition did not require the presence of agonist, and GABA-activated current recovered completely from inhibition by bis(7)-tacrine in the absence of agonist. The slow onset of inhibition by bis(7)-tacrine was not apparently due to an action at an intracellular site, as inclusion of 25 μM bis(7)-tacrine in the recording pipette did not alter inhibition by bis(7)-tacrine applied externally. Bis(7)-tacrine shifted the GABA concentration-response curve to the right in a parallel manner and the pA 2 value estimated from a Schild plot was 5.7. Bis(7)-tacrine increased the time constant of activation of GABA-gated ion channels without affecting the time constants of deactivation or desensitization. These results suggest that bis(7)-tacrine is a competitive GABA A receptor antagonist with slow onset and offset kinetics. The competitive inhibition of GABA receptors by bis(7)-tacrine could contribute to its ability to enhance memory.
机译:Bis(7)-他克林是衍生自他克林的新型二聚乙酰胆碱酯酶抑制剂,对治疗阿尔茨海默氏病显示出希望。我们以前曾报道过bis(7)-他克林抑制GABA A受体。在本研究中,我们研究了在培养的大鼠海马神经元中使用全细胞膜片钳记录的bis(7)-他克林抑制GABA A受体功能的机制。 Bis(7)-他克林使GABA激活电流逐渐下降至稳态,但这并不表示使用依赖,因为逐渐下降的成分可通过在使用bis(7)-他克林之前暴露而消除到GABA应用程序。此外,bis(7)-他克林的抑制作用不需要激动剂的存在,而在没有激动剂的情况下,GABA激活的电流完全可以从bis(7)-他克林的抑制作用中恢复。 bis(7)-他克林抑制作用的缓慢起效显然不是由于细胞内部位的作用所致,因为在记录移液管中加入25μMbis(7)-他克林不会改变bis(7)-他克林的抑制作用外部应用。 Bis(7)-他克林以平行的方式将GABA浓度-响应曲线向右移动,根据Schild图估算的pA 2值为5.7。 Bis(7)-他克林增加了GABA门控离子通道激活的时间常数,而不影响失活或脱敏的时间常数。这些结果表明,bis(7)-他克林是一种竞争性GABA A受体拮抗剂,具有缓慢的起效和抵消动力学。 bis(7)-他克林对GABA受体的竞争性抑制作用可能有助于其增强记忆力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号